Profiel
Andrew Keck is associated with Tyme Technologies, Inc. He was the President, CEO, CFO, Secretary & Treasurer of the company from 2011 to 2013.
He is the founder of Tyme Technologies, Inc. which was founded in 2011.
Eerdere bekende functies van Andrew Keck
Bedrijven | Functie | Einde |
---|---|---|
TYME TECHNOLOGIES, INC. | Algemeen Directeur | 26-04-2013 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Tyme Technologies, Inc.
Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |